Skip to main content
SpringerLink
Log in

Antidepressants and Suicide Risk: A Challenge

  • Chapter
  • First Online:
Understanding Suicide

  • 2291 Accesses

Abstract

The topic of whether antidepressant drugs increase or decrease the risk of various aspects of “suicidality” is still controversial, especially among patients with a mood disorder diagnosis. Recent data has shown a possible increase in risk of suicidal behavior among children and adolescents treated with selective serotonin reuptake inhibitors (SSRIs). In 2004, the Food and Drug Administration (FDA) established that antidepressant drugs should display a black box on their label, with warning information about the elevated risk of suicidal behavior in individuals aged 18–24 years. Research on the relationship between pharmacotherapy and suicidal behavior was virtually nonexistent until a decade ago. Since then, several studies have demonstrated that antidepressants reduce suicide risk among psychiatric patients, whereas others have found an increase in suicide risk during antidepressant treatment. Close monitoring is critical, and prudent follow-up care should be provided for patients prescribed with antidepressants.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acharya N, Rosen AS, Polzer JP, D’Souza DN, Perahia DG, Cavazzoni PA, Baldessarini RJ (2006) Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol 26:587–594

    Article  CAS  PubMed  Google Scholar 

  • Akiskal HS, Benazzi F, Perugi G, Rihmer Z (2005) Agitated “unipolar” depression reconceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 85:245–258

    Article  PubMed  Google Scholar 

  • American Psychiatric Association (2003) Practice guideline for the assessment and treatment of patients with suicidal behaviors. American Psychiatric Association, Arlington

    Google Scholar 

  • Angst J, Angst F, Gerber-Werder R, Gamma A (2005) Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up. Arch Suicide Res 9:279–300

    Article  PubMed  Google Scholar 

  • Bailly D (2009) Antidepressant use in children and adolescents. Arch Pediatr 16:1415–1418

    Article  CAS  PubMed  Google Scholar 

  • Baldessarini RJ, Willmuth RL (1968) Psychotic reactions during amitriptyline therapy. Can Psychiatr Assoc J 13:571–573

    CAS  PubMed  Google Scholar 

  • Baldessarini RJ, Salvatore P, Tohen M, Khalsa HMK, Hennen J, González-Pinto A, Baethge C, Tohen M (2004) Morbidity from onset in first-episode bipolar I disorder patients: the international-300 study. Neuropsychopharmacology 29:S88

    Google Scholar 

  • Baldessarini RJ, Pompili M, Tondo L (2006) Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry 63:246–248

    Article  PubMed  Google Scholar 

  • Barak Y, Aizenberg D (2006) Association between antidepressant prescribing and suicide in Israel. Int Clin Psychopharmacol 21:281–284

    Article  PubMed  Google Scholar 

  • Barak Y, Olmer A, Aizenberg D (2006) Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology 31:178–181

    CAS  PubMed  Google Scholar 

  • Barber C, Azrael D, Miller M (2014) Study findings on FDA antidepressant warnings and suicide attempts in young people: a false alarm? BMJ 349:g5645

    Article  PubMed  Google Scholar 

  • Barbui C, Campomori A, D’Avanzo B, Negri E, Garattini S (1999) Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol 34:152–156

    Article  CAS  PubMed  Google Scholar 

  • Barbui C, Furukawa TA, Cipriani A (2008) Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ 178:296–305

    Article  PubMed  PubMed Central  Google Scholar 

  • Barbui C, Esposito E, Cipriani A (2009) Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 180:291–297

    Article  PubMed  PubMed Central  Google Scholar 

  • Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS (2006) Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 67:48–55

    Article  CAS  PubMed  Google Scholar 

  • Carlsten A, Waern M, Ekedahl A, Ranstam J (2001) Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 10:525–530

    Article  CAS  PubMed  Google Scholar 

  • Cooper WO, Callahan ST, Shintani A, Fuchs DC, Shelton RC, Dudley JA, Graves AJ, Ray WA (2014) Antidepressants and suicide attempts in children. Pediatrics 133:204–210

    Article  PubMed  PubMed Central  Google Scholar 

  • Davis A, Gilhooley M, Agius M, Zaman R (2010) Suicide risk and choice of antidepressant. Psychiatr Danub 22:358–359

    PubMed  Google Scholar 

  • Didham RC, McConnell DW, Blair HJ, Reith DM (2005) Suicide and self-harm following prescription of SSRIs and other antidepressants: Confounding by indication. Br J Clin Pharmacol 60:519–525

    Article  PubMed  PubMed Central  Google Scholar 

  • Drapeau CW, McIntosh JL, for the American Association of Suicidology (2014) U.S.A. suicide 2012: official final data. American Association of Suicidology, Washington, DC

    Google Scholar 

  • Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330:396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62:165–172

    Article  CAS  PubMed  Google Scholar 

  • Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ (2004) Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry 65:1456–1462

    Article  PubMed  Google Scholar 

  • Gunnell D, Saperia J, Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. BMJ 330:385

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P (2003) Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ 326:1008

    Article  PubMed  PubMed Central  Google Scholar 

  • Hammad T, Laughren T, Racoosin JA (2006a) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332–339

    Article  CAS  PubMed  Google Scholar 

  • Hammad TA, Laughren TP, Racoosin JA (2006b) Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol 26:203–207

    Article  CAS  PubMed  Google Scholar 

  • Harris EC, Barraclough B (1998) Excess mortality of mental disorder. Br J Psychiatry 173:11–53

    Article  CAS  PubMed  Google Scholar 

  • Healy D, Whitaker C (2003) Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci 28:331–337

    PubMed  PubMed Central  Google Scholar 

  • Isacsson G (2000) Suicide prevention – a medical breakthrough? Acta Psychiatr Scand 102:113–117

    Article  CAS  PubMed  Google Scholar 

  • Jick SS, Dean AD, Jick H (1995) Antidepressants and suicide. BMJ 310:215–218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jick H, Kaye JA, Jick SS (2004) Antidepressants and the risk of suicidal behaviors. JAMA 292:338–343

    Article  CAS  PubMed  Google Scholar 

  • Juurlink DN, Mamdani MM, Kopp A, Redelmeier DA (2006) The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 163:813–821

    Article  PubMed  Google Scholar 

  • Kasper S, Montgomery SA, Moller HJ, van Oers HJ, Jan Schutte A, Vrijland P, van der Meulen EA (2010) Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder. World J Biol Psychiatry 11:36–44

    Article  PubMed  Google Scholar 

  • Khan A, Warner HA, Brown WA (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 57:311–317

    Article  CAS  PubMed  Google Scholar 

  • Khan A, Leventhal RM, Khan S, Brown WA (2002) Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database. J Affect Disord 68:183–190

    Article  PubMed  Google Scholar 

  • Khan A, Khan S, Kolts R, Brown WA (2003) Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 160:790–792

    Article  PubMed  Google Scholar 

  • Laughren T, Levin R (2006) Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim. Schizophr Bull 32:220–222

    Article  PubMed  PubMed Central  Google Scholar 

  • Leon AC (2007) The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. Am J Psychiatry 164:1786–1789

    Article  PubMed  Google Scholar 

  • Leon AC, Keller MB, Warshaw MG, Mueller TI, Soloman DA, Coryell W, Endicott J (1999) A prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am J Psychiatry 156:195–201

    CAS  PubMed  Google Scholar 

  • Levi F, La Vecchia C, Lucchini F, Negri E, Saxena S, Maulik PK, Saraceno B (2003) Trends in mortality from suicide, 1965–99. Acta Psychiatr Scand 108:341–349

    Article  CAS  PubMed  Google Scholar 

  • Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G et al (2014) Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ 348:g3596. doi:10.1136/bmj.g3596

    Article  PubMed  PubMed Central  Google Scholar 

  • Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L (2006) Agitated “unipolar” major depression: prevalence, phenomenology, and outcome. J Clin Psychiatry 67:712–719

    Article  PubMed  Google Scholar 

  • Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D (2005) Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 330:389

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Masi G, Liboni F, Brovedani P (2010) Pharmacotherapy of major depressive disorder in adolescents. Expert Opin Pharmacother 11:375–386

    Article  CAS  PubMed  Google Scholar 

  • Matthews JD, Fava M (2000) Risk of suicidality in depression with serotonergic antidepressants. Ann Clin Psychiatry 12(1):43–50

    Article  CAS  PubMed  Google Scholar 

  • MHRA (UK Medicines and Health Regulatory Agency) Selective serotonin reuptake inhibitor (SSRI) antidepressants: Committee on Safety of Medicines (CSM) working group findings. Available online: http://www.mhra.gov.uk/news/2004/2004.htm

  • Moller HJ, Baldwin DS, Goodwin G, Kasper S, Okasha A, Stein DJ, Tandon R, Versiani M (2008) Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci 258(Suppl 3):3–23

    Article  PubMed  Google Scholar 

  • Morgan OW, Griffiths C, Majeed A (2004) Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health 4:63

    Article  PubMed  PubMed Central  Google Scholar 

  • Olfson M, Marcus SC, Shaffer D (2006) Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry 63:865–872

    Article  PubMed  Google Scholar 

  • Oquendo MA, Kamali M, Ellis SP, Grunebaum MF, Malone KM, Brodsky BS, Sackeim HA, Mann JJ (2002) Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study. Am J Psychiatry 159:1746–1751

    Article  PubMed  Google Scholar 

  • Oquendo MA, Chaudhury SR, Mann JJ (2005) Pharmacotherapy of suicidal behavior in bipolar disorder. Arch Suicide Res 9:237–250

    Article  PubMed  Google Scholar 

  • Pompili M (2010) Exploring the phenomenology of suicide. Suicide Life Threat Behav 40(3):234–244

    Article  PubMed  Google Scholar 

  • Pompili M, Tondo L, Baldessarini RJ (2005) Suicidal risk emerging during antidepressant treatment: recognition and intervention. Clin Neuropsychiatr 2:66–72

    Google Scholar 

  • Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE Jr, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA (2003) Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 64:680–690; quiz 738–789

    Article  PubMed  Google Scholar 

  • Reeves RR, Ladner ME (2010) Antidepressant-induced suicidality: an update. CNS Neurosci Ther 16:227–234

    PubMed  Google Scholar 

  • Rihmer Z (2001) Can better recognition and treatment of depression reduce suicide rates? A brief review. Eur Psychiatry 16:406–409

    Article  CAS  PubMed  Google Scholar 

  • Rihmer Z (2003) Do SSRIs increase the risk of suicide among depressives even if they are taking only placebo? Psychother Psychosom 72:357–358; author reply 359–360

    Article  PubMed  Google Scholar 

  • Rihmer Z, Appleby L, Rihmer A, Belso N (2000) Decreasing suicide in Hungary. Br J Psychiatry 177:84

    Article  CAS  PubMed  Google Scholar 

  • Roy A (2000) Suicide. In: Sadock BJ, Sadock VA (eds) Kaplan and Sadock’s comprehensive textbook of psychiatry, vol 2, 7th edn. Lippincott Willians and Wilkins, Philadelphia, pp 2031–2040

    Google Scholar 

  • Schneeweiss S, Patrick AR, Solomon DH, Dormuth CR, Miller M, Mehta J, Lee JC, Wang PS (2010) Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics 125:876–888

    Article  PubMed  PubMed Central  Google Scholar 

  • Shneidman ES (1993) Suicide as psychache. J Nerv Ment Dis 181(3):145–147

    Article  CAS  PubMed  Google Scholar 

  • Simon GE, Savarino J, Operskalski B, Wang PS (2006) Suicide risk during antidepressant treatment. Am J Psychiatry 163:41–47

    Article  PubMed  Google Scholar 

  • Sondergard L, Kvist K, Andersen PK, Kessing LV (2006a) Do antidepressants prevent suicide? Int Clin Psychopharmacol 21:211–218

    Article  PubMed  Google Scholar 

  • Sondergard L, Kvist K, Andersen PK, Kessing LV (2006b) Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study. Eur Child Adolesc Psychiatry 15:232–240

    Article  PubMed  Google Scholar 

  • Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:b2880

    Article  PubMed  PubMed Central  Google Scholar 

  • Storosum JG, van Zwieten BJ, van den Brink W, Gersons BP, Broekmans AW (2001) Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 158:1271–1275

    Article  CAS  PubMed  Google Scholar 

  • Teicher MH, Glod CA, Cole JO (1993) Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 8:186–212

    Article  CAS  PubMed  Google Scholar 

  • Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63:1358–1367

    Article  CAS  PubMed  Google Scholar 

  • Tollefson GD, Rampey AH Jr, Beasley CM Jr, Enas GG, Potvin JH (1994) Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol 14:163–169

    CAS  PubMed  Google Scholar 

  • Tondo L, Isacsson G, Baldessarini RJ (2003) Suicide in bipolar disorder: risk and prevention. CNS Drugs 17:491–511

    Article  CAS  PubMed  Google Scholar 

  • Turecki G, Ernst C, Jollant F, Labonté B, Mechawar N (2012) The neurodevelopmental origins of suicidal behavior. Trends Neurosci 35(1):14–23

    Article  CAS  PubMed  Google Scholar 

  • U.S. Food and Drug Administration (FDA) (2004) Antidepressant use in children, adolescents, and adults. Available online: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/-UCM096273

  • U.S. Food and Drug Administration (FDA) (2007) Antidepressant use in children, adolescents, and adults. Available online: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/-UCM096273

  • Warshaw MG, Keller MB (1996) The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 57:158–166

    CAS  PubMed  Google Scholar 

  • World Health Organization (WHO) (2010) International suicide rates. Available online: www.who.int/mental_health/prevention/suicide/country_reports/en/index.html/

  • Yerevanian BI, Koek RJ, Feusner JD, Hwang S, Mintz J (2004) Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatr Scand 110:452–458

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy

    Maurizio Pompili & Gloria Giordano

  2. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA

    Dorian A. Lamis

Authors
  1. Maurizio Pompili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gloria Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dorian A. Lamis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurizio Pompili .

Editor information

Editors and Affiliations

  1. Academic Hospital of Montpellier, University of Montpellier, Montpellier, France

    Philippe Courtet

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pompili, M., Giordano, G., Lamis, D.A. (2016). Antidepressants and Suicide Risk: A Challenge. In: Courtet, P. (eds) Understanding Suicide. Springer, Cham. https://doi.org/10.1007/978-3-319-26282-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26282-6_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26280-2

  • Online ISBN: 978-3-319-26282-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation